Cargando…
lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358600/ https://www.ncbi.nlm.nih.gov/pubmed/34457053 http://dx.doi.org/10.3892/ol.2021.12959 |
| _version_ | 1783737376823050240 |
|---|---|
| author | Yamada, Hideharu Takahashi, Masanobu Watanuki, Munenori Watanabe, Mika Hiraide, Sakura Saijo, Ken Komine, Keigo Ishioka, Chikashi |
| author_facet | Yamada, Hideharu Takahashi, Masanobu Watanuki, Munenori Watanabe, Mika Hiraide, Sakura Saijo, Ken Komine, Keigo Ishioka, Chikashi |
| author_sort | Yamada, Hideharu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8358600 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | D.A. Spandidos |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83586002021-08-26 lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma Yamada, Hideharu Takahashi, Masanobu Watanuki, Munenori Watanabe, Mika Hiraide, Sakura Saijo, Ken Komine, Keigo Ishioka, Chikashi Oncol Lett Corrigendum D.A. Spandidos 2021-10 2021-08-02 /pmc/articles/PMC8358600/ /pubmed/34457053 http://dx.doi.org/10.3892/ol.2021.12959 Text en Copyright: © Yamada et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
| spellingShingle | Corrigendum Yamada, Hideharu Takahashi, Masanobu Watanuki, Munenori Watanabe, Mika Hiraide, Sakura Saijo, Ken Komine, Keigo Ishioka, Chikashi lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title | lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title_full | lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title_fullStr | lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title_full_unstemmed | lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title_short | lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| title_sort | lncrna har1b has potential to be a predictive marker for pazopanib therapy in patients with sarcoma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358600/ https://www.ncbi.nlm.nih.gov/pubmed/34457053 http://dx.doi.org/10.3892/ol.2021.12959 |
| work_keys_str_mv | AT yamadahideharu lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT takahashimasanobu lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT watanukimunenori lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT watanabemika lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT hiraidesakura lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT saijoken lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT kominekeigo lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma AT ishiokachikashi lncrnahar1bhaspotentialtobeapredictivemarkerforpazopanibtherapyinpatientswithsarcoma |